Oragenics
OGEN
8 hedge funds and large institutions have $28.8M invested in Oragenics in 2014 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
32% less capital invested
Capital invested by funds: $42.7M → $28.8M (-$13.9M)
33% less funds holding
Funds holding: 12 → 8 (-4)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$79K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$158K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$54K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$39.5K |
| 4 |
SIM
Spark Investment Management
New York
|
-$37K |
| 5 |
N
Natixis
Paris,
France
|
-$34K |
OGEN Hedge Fund Activity: Q2 2014 in Review
8 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q2 2014, worth a combined $28.8M — down 32% from $42.7M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of OGEN and 0 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Janney Montgomery Scott, adding an estimated $79K. The largest seller was Fidelity Investments, cutting an estimated $158K.
- 8 institutional investors held Oragenics (OGEN) as of Q2 2014, down from 12 in Q1 2014.
- Funds reported $28.8M of Oragenics stock for Q2 2014, down 32% quarter-over-quarter.
- 0 funds opened new Oragenics positions in Q2 2014 and 4 closed out, a net change of -4 holders.
- The largest Oragenics buyer in Q2 2014 was Janney Montgomery Scott, an estimated $79K added.
- The largest Oragenics seller in Q2 2014 was Fidelity Investments, an estimated $158K sold.
Based on aggregated 13F filings for Q2 2014.